Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.3B | 6.9B | 6.3B | 6.2B |
Cost of revenue | 4.5B | 4.5B | 4.3B | 4.2B |
Gross profit | 2.8B | 2.4B | 2.1B | 2.0B |
Operating expense | ||||
Research & development | 201.7M | 206.5M | 171.3M | 160.0M |
Selling general and admin | 796.4M | 845.0M | 705.4M | 749.7M |
Other operating expenses | — | — | — | — |
Operating income | 1.8B | 1.3B | 1.2B | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 6.9M | 8.0M | 7.1M | 8.4M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 1.6B | 1.1B | 1.3B |
Tax provision | 374.6M | 292.3M | 227.0M | 252.9M |
Net income | 1.5B | 1.3B | 895.4M | 1.1B |
Basic EPS | 2.5 | — | 1.5 | 1.8 |
Diluted EPS | 2.5 | — | 1.5 | 1.8 |
Basic average shares | 591.5M | — | 592.5M | 591.4M |
Diluted average shares | 591.5M | — | 592.5M | 591.4M |
EBITDA | 2.6B | 2.3B | 1.8B | 2.0B |
Net income from continuing op. | 1.9B | 1.6B | 1.1B | 1.3B |
Minority interests | -37.5M | -18.0M | -12.7M | -24.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |